Skip to main content
Clinical Trials/NCT03227991
NCT03227991
Completed
Not Applicable

Safety Planning Intervention to Reduce Short Term Risk

New York State Psychiatric Institute3 sites in 1 country422 target enrollmentSeptember 10, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Suicide, Attempted
Sponsor
New York State Psychiatric Institute
Enrollment
422
Locations
3
Primary Endpoint
Suicide, attempted and suicide
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This study will determine the efficacy of Safety Planning Intervention (SPI) compared to receiving risk factors and warning sign information (RWI) in recent suicide attempters during the 6 months following an acute care visit on: (1) suicidal behaviors; (2) mental health/substance use treatment engagement; (3) suicide-related coping strategies; (4) suicidal ideation; and (5) use of means restriction.

Detailed Description

There is a pressing need for improved acute care setting suicide prevention interventions. The Safety Planning Intervention (SPI) is a protocol driven, brief suicide prevention strategy that is a good fit for acute care settings (i.e., emergency departments (ED) and inpatient units). The SPI involves a clinician working collaboratively with the patient to build a personalized safety plan that is documented using a templated paper form and includes warning sign identification, means restriction and personalized strategies to deescalate a suicide crisis. It is easy to learn and administer, acceptable to patients, brief, firmly rooted in an empirical base and has preliminary studies supporting its feasibility and potential to impact patient outcomes, including suicidal behavior and treatment engagement. However, while it is being adopted widely, it lacks a randomized controlled trial (RCT) to definitively determine its efficacy. The purpose of this study to conduct a randomized control trial of the Safety Planning Intervention (SPI) compared with receiving risk factors and warning sign information (RWI) in acute care settings. All participants in this study will complete some baseline assessments, following which they will be randomly assigned to one of two study conditions: Safety Plan Intervention (SPI) or receiving risk factors and warning sign information (RWI). If assigned to SPI, participants will receive the assigned intervention by the research clinician. They will receive a paper copy of their safety plan while in the ED or on the inpatient unit and a back-up copy will be sent approximately 1 week after discharge to participants. For RWI participants, ED and inpatient unit care will be delivered as usual, with the addition of a printed information sheet listing suicide risk factors and crisis hotlines. In addition to the baseline assessment, multi-method outcome assessment will be conducted at 1, 3, and 6 months. This will include telephone evaluations by a blinded assessor (not the research clinician), medical record review, and vital statistics registry review.

Registry
clinicaltrials.gov
Start Date
September 10, 2017
End Date
June 30, 2020
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Beth Brodsky

Associate Director

New York State Psychiatric Institute

Eligibility Criteria

Inclusion Criteria

  • Presented for an acute care visit within 8 weeks of a suicide attempt, interrupted or aborted attempt, or suicidal ideation with intent and plan within 4 weeks.
  • Are 18 years of age or older
  • Able to speak and read English
  • Able to understand the nature of the study, provide written informed consent, and complete study procedures
  • Have been evaluated by a health care professional who provides permission for research staff to approach the patient.

Exclusion Criteria

  • Under 18 years of age
  • Cannot speak or read English
  • Unable to understand the nature of the study, provide written informed consent, or complete study procedures
  • Unable or unwilling to provide a personal phone number for follow up purposes.

Outcomes

Primary Outcomes

Suicide, attempted and suicide

Time Frame: 6 months

As measured by the Columbia Suicide Severity Rating Scale (C-SSRS); responses are yes-no with yes more severe

Secondary Outcomes

  • Suicide related coping(6 months)
  • Suicidal ideation intensity(6 months)
  • Suicidal ideation severity(6 months)
  • Suicide, attempted, aborted, interrupted attempt or preparatory suicidal behavior(6 months)
  • Means restriction(6 months)
  • Treatment engagement(6 months)

Study Sites (3)

Loading locations...

Similar Trials